AXON
IndustrialsAxon Enterprise
Price Chart
Market Data
Financials
XBRL · SEC EDGAR2009–2025(17yr)| Metric | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025Latest | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $104.3M | $86.9M | $90.0M | $114.8M | $137.8M | $164.5M | $197.9M | $268.2M | $343.8M | $420.1M | $530.9M | $681.0M | $863.4M | $1.2B | $1.6B | $2.1B | $2.8B | +33.5% |
| Gross Profit | $63.4M | $45.4M | $44.5M | $67.7M | $85.8M | $101.5M | $128.6M | $170.5M | $207.1M | $258.6M | $307.3M | $416.3M | $540.9M | $728.6M | $955.4M | $1.2B | $1.7B | +33.6% |
| Gross Margin | 60.8% | 52.2% | 49.5% | 59.0% | 62.3% | 61.7% | 65.0% | 63.6% | 60.2% | 61.6% | 57.9% | 61.1% | 62.7% | 61.2% | 61.1% | 59.6% | 59.7% | +0.0pp |
| Operating Income | -$79.2K | -$5.1M | -$10.9M | $22.5M | $27.9M | $32.5M | $35.3M | $31.9M | $13.0M | $24.8M | -$6.4M | -$14.2M | -$168.1M | $93.3M | $154.8M | $58.5M | -$62.1M | -206.0% |
| Operating Margin | -0.1% | -5.9% | -12.1% | 19.6% | 20.3% | 19.8% | 17.9% | 11.9% | 3.8% | 5.9% | -1.2% | -2.1% | -19.5% | 7.8% | 9.9% | 2.8% | -2.2% | -5.0pp |
| Net Income | -$1.1K | -$4.4M | -$7.0M | $14.7M | $18.2M | $19.9M | $19.9M | $17.3M | $5.2M | $29.2M | $882.0K | -$1.7M | -$60.0M | $147.1M | $174.2M | $377.0M | $124.7M | -66.9% |
| Net Margin | -0.0% | -5.0% | -7.8% | 12.8% | 13.2% | 12.1% | 10.1% | 6.4% | 1.5% | 7.0% | 0.2% | -0.3% | -7.0% | 12.4% | 11.1% | 18.1% | 4.5% | -13.6pp |
| Free Cash Flow | -$3.6M | -$3.3M | $15.4M | $25.2M | $30.6M | $32.9M | $40.4M | $13.0M | $8.1M | $52.7M | $49.7M | -$34.1M | $74.6M | $179.6M | $129.6M | $329.5M | $75.1M | -77.2% |
| FCF Margin | -3.4% | -3.8% | 17.1% | 21.9% | 22.2% | 20.0% | 20.4% | 4.8% | 2.3% | 12.6% | 9.4% | -5.0% | 8.6% | 15.1% | 8.3% | 15.8% | 2.7% | -13.1pp |
| EPS (Diluted) | $0.00 | $-0.07 | $-0.12 | $0.27 | $0.34 | $0.37 | $0.36 | $0.32 | $0.10 | $0.50 | $0.01 | $-0.03 | $-0.91 | $2.03 | $2.31 | $4.80 | $1.51 | -68.5% |
1. THE BIG PICTURE
Axon is no longer just a hardware vendor; it is building a "public safety operating system" that ties law enforcement agencies to a high-margin software ecosystem through integrated devices (10-K Item 1). While revenue growth is leading its peer group at 33.5%, Axon Enterprise is currently sacrificing immediate profitability and cash flow to fund an aggressive pivot into AI-enabled productivity tools (XBRL, 8-K).
2. WHERE THE RISKS HIT HARDEST
The "Integrated Ecosystem" advantage is threatened by SaaS deployment and IT infrastructure risks because the value of Axon’s hardware depends entirely on the reliability of its cloud-hosted evidence management platform (10-K Item 1, Risks). If Axon fails to scale its infrastructure, it risks losing the recurring software revenue that justifies its current valuation. Furthermore, the growth of the Connected Devices segment is threatened by regulatory risks; if the TASER 10 is reclassified as a firearm, stricter transfer requirements could dampen the 38% growth currently driven by that product line (10-K Item 1, 8-K).
3. WHAT THE NUMBERS SAY TOGETHER
Axon’s financial profile reveals a company in a period of intense transition. It ranks first among peers in revenue growth (+33.5% TTMTTMTrailing Twelve Months — the most recent full year of financial data, updated on a rolling basis each quarter) but sits at the bottom for operating margin (0.5%) and free cash flow margin (-0.6%) (XBRL). This divergence is explained by a strategic shift toward "aggressive AI integration," with management prioritizing R&DR&DResearch & Development — spending on creating new products or technologies and stock-based compensation—projected as high as $620 million for 2026—over near-term earnings (8-K).
The 39% revenue growth in the most recent quarter exceeds the TTMTTMTrailing Twelve Months — the most recent full year of financial data, updated on a rolling basis each quarter average, suggesting that the rollout of the TASER 10 and "premium software adoption" are currently accelerating the business (8-K). However, with short interest at 3.7% of the float, a segment of the market remains skeptical that this growth can eventually be converted into peer-leading cash flows (Yahoo Finance). While Axon’s 60.4% gross margin is exceptional for a business where hardware represents over half of the revenue, its negative FCFFCFFree Cash Flow — cash left after paying for operations and capital investments; what the company can actually spend, save, or return to shareholders margin highlights the high cost of maintaining its competitive lead (XBRL).
4. IS IT WORTH IT AT THIS PRICE?
At 50.4x Forward P/EP/EPrice-to-Earnings ratio — share price divided by annual earnings per share; how much investors pay per dollar of profit. Higher P/E = higher growth expectations, the market is pricing in ~11.0% long-term growth (CAPM analysis). This represents an 89% premium to the peer median Forward P/EP/EPrice-to-Earnings ratio — share price divided by annual earnings per share; how much investors pay per dollar of profit. Higher P/E = higher growth expectations of 26.7x (Yahoo Finance). This premium is supported by Axon’s superior revenue growth and its 2028 target of $6 billion in annual revenue (8-K).
However, the valuation is highly sensitive to any deceleration. If long-term growth expectations were to moderate to 9.5%, the justified multiple would fall to 29.6x—a roughly 41% decline from current levels (CAPM analysis). Investors are currently paying a significant premium for Axon’s "network effect" in digital evidence management, but the primary risk to this price is Axon Enterprise's negative free cash flow (-0.6%) compared to peers like Verisk, which generates a 38.3% FCFFCFFree Cash Flow — cash left after paying for operations and capital investments; what the company can actually spend, save, or return to shareholders margin (XBRL).
5. WHAT WOULD CHANGE THIS VIEW?
- Cautious if free cash flow remains negative throughout 2026, suggesting that the costs of the AI Era Plan are outstripping the benefits of software scaling.
- Constructive if Software & Services growth accelerates beyond 40%, signaling that AI tools like "Draft One" are achieving rapid market penetration (8-K).
- Cautious if federal or state regulators reclassify Conducted Energy Devices as firearms, which would create immediate friction in the sales cycle (10-K Item 1).
6. BOTTOM LINE
Structural Advantage: High switching costs and a powerful network effect created by the integration of TASER hardware with a proprietary digital evidence management platform. Bottom Line: Axon is a dominant category leader with explosive growth, but its current valuation demands flawless execution of its AI strategy and a swift return to positive cash flow.
1. Top 5 Material Risks
- Dependence on Law Enforcement Demand: Axon Enterprise relies heavily on U.S. federal, state, and local law enforcement agencies. Any reduction in demand for CEDs or other products, whether due to negative publicity, budget constraints, or political factors, would materially harm Axon Enterprise’s financial condition.
- Market Acceptance of CEDs: A significant portion of revenue is derived from CEDs. Failure to maintain widespread market acceptance or meet evolving customer requirements for these products would diminish growth prospects and operating results.
- SaaS Deployment and IT Infrastructure: Axon Enterprise devotes significant resources to SaaS solutions. If it cannot scale its IT infrastructure to meet demand or fails to deploy new features successfully, it risks losing customers to competitors and incurring substantial costs.
- Rapid Technological Change: The market for law enforcement technology is evolving quickly, particularly regarding AI and machine learning. If Axon Enterprise fails to keep pace with new competing products or industry standards, its competitive position and financial results could suffer.
- Negative Publicity: The Axon brand is central to the business. Negative publicity—whether related to product safety, legal proceedings, or social issues—can reduce demand, damage the brand, and lead to lower sales and earnings.
2. Company-Specific Risks
- Supply Chain Concentration: Axon Enterprise relies on a limited number of suppliers for critical components, including semiconductors and custom parts for the TASER 10 CED, which cannot be easily replaced.
- Lengthy Sales Cycles: Axon Enterprise expends significant resources during lengthy sales cycles—ranging from weeks to years—with no guarantee of revenue, which can lead to wasted selling costs.
- Cybersecurity and Data Privacy: As a provider of cloud services to law enforcement, a breach of Axon Enterprise’s network or third-party cloud providers could lead to significant legal exposure, financial liabilities, and loss of customer trust.
- Key Personnel Retention: Axon Enterprise does not maintain key person insurance and relies on the continued service of senior management, including the CEO, and specialized technical talent, such as AI engineers.
3. Regulatory/Legal Risks
- Firearm Regulation: The TASER 10 CED is regulated by the ATF under the National Firearms Act and the Gun Control Act. Failure to comply with these federal rules, or changes in state/local laws regarding firearm features, could result in fines, production suspensions, or product bans.
- Intellectual Property Litigation: Axon Enterprise is subject to ongoing and potential future patent infringement claims from competitors and non-practicing entities, which could force Axon Enterprise to pay royalties, discontinue products, or incur substantial legal fees.
- AI Governance: Axon Enterprise faces evolving regulatory requirements for AI, such as the European Union’s AI Act, which imposes compliance obligations on law enforcement technology providers.
- Exclusive Forum Provisions: Axon Enterprise’s bylaws mandate that the Chancery Court of Delaware is the exclusive forum for derivative actions and internal affairs claims, which may discourage shareholder litigation or increase costs for plaintiffs.
4. Financial Impact Map
Dependence on Law Enforcement Demand → Revenue → Significant portion of total revenue is derived from CEDs and related services sold to law enforcement.
SaaS Subscription Model → Accounts Receivable / Contract Assets → Increasing percentage of revenue derived from subscription billing results in delayed cash collections and higher credit risk.
Acquisitions and Investments → Goodwill / Intangible Assets → Significant acquisitions result in the recognition of goodwill; underperformance could lead to non-cash impairment charges.
Product Liability Claims → Operating Expenses / Legal Reserves → Potential for significant adverse judgments or settlements in excess of insurance coverage.
Internal Control Deficiencies → Financial Reporting / Stock Price → Failure to remediate material weaknesses in revenue recognition could lead to inaccurate financial reporting and a decline in common stock value.
Recent Filings
| Form | Filed | Period |
|---|---|---|
| 10-K | Feb 2026 | Dec 2025 |
| 8-K | Feb 2026 | — |
| 10-Q | Nov 2025 | Sep 2025 |
| 14A | Apr 2025 | — |
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
Axon Q4 Revenue $797M Beats Estimates by 5.7%, EPS $2.15 Tops Consensus
- ▸Q4 revenue $797M, +39% YoY, beating $753.6M estimate
- ▸Q4 adjusted EPS $2.15, beating $1.67 estimate
- ▸FY2025 total revenue $2.78B, +33.5% YoY
- ▸Connected Devices revenue $454.2M, +37.6% YoY
- ▸Software & Services revenue $342.5M, +39.8% YoY
Axon 2025 Adjusted EBITDA $710M +36.3%, Q4 Revenue $797M +39% YoY
- ▸2025 adjusted EBITDA $710M, up 36.3% YoY
- ▸2025 adjusted EBITDA margin 25.5%, up 50 bps
- ▸Q4 2025 revenue $797M, up 39% YoY
- ▸2025 gross margin 59.7%, up 10 bps
- ▸2026 adjusted EBITDA margin guidance approximately 25.5%
Axon projects 27-30% revenue growth for 2026 amid strong software demand
- ▸Software & Services revenue +39.6% YoY in 2025
- ▸FY2026 revenue growth guidance set at 27-30% YoY
- ▸Strong demand for Dedrone platform expected from NATO airspace defense agencies
- ▸2026 earnings consensus estimate increased 4.8% over past 60 days
- ▸Axon shares gained 14.8% over the past month
Axon Q4 Revenue $797M +39% YoY, Sets 2028 Revenue Target of $6B
- ▸Q4 revenue $797M, up 39% YoY
- ▸FY26 revenue growth guidance 27%–30%
- ▸FY26 adjusted EBITDA margin target 25.5%
- ▸Long-term 2028 annual revenue target set at $6B
- ▸Consensus analyst rating remains Strong Buy with $740.50 price target